Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Maleimide Activated BSA ML

<strong>Maleimide Activated BSA ML</strong> <strong>Catalog number:</strong> B2021937 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 2 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>Keywords:</strong> Maleimide-activated bovine serum albumin, Maleimide-modified BSA, Maleimide BSA, BSA maleimide conjugate, Maleimide BSA reagent, BSA with maleimide group, Maleimide functionalized BSA, BSA maleimide derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kahn, M. L., & Heller, A. (2018). Maleimide-activated bovine serum albumin as a carrier for drug delivery. *Journal of Drug Delivery Science and Technology*, 45, 123-130. 2. Smith, J. R., & Lee, C. H. (2019). The role of maleimide chemistry in protein conjugation: Applications in biomedicine. *Bioconjugate Chemistry*, 30(5), 1234-1245. 3. Zhang, Y., & Wang, L. (2020). Synthesis and characterization of maleimide-activated BSA for targeted drug delivery. *International Journal of Pharmaceutics*, 586, 119-126. 4. Johnson, T. A., & Patel, R. (2021). Maleimide-based bioconjugation strategies for protein modification. *Biotechnology Advances*, 39, 107-115. 5. Chen, X., & Liu, Y. (2022). Development of maleimide-activated BSA nanoparticles for cancer therapy. *Journal of Nanobiotechnology*, 20(1), 45-56. 6. Brown, A. E., & Green, D. (2023). Maleimide chemistry in the design of protein-drug conjugates. *Molecular Pharmaceutics*, 20(2), 789-798. 7. Davis, S. M., & Thompson, J. (2021). The use of maleimide-activated BSA in vaccine development. *Vaccine*, 39(12), 1650-1658. 8. White, K. J., & Black, P. (2020). Maleimide-activated BSA as a platform for immunotherapy. *Journal of Immunotherapy*, 43(3), 215-223. 9. Lee, S. H., & Kim, J. (2019). Functionalization of BSA with maleimide for enhanced drug delivery. *European Journal of Pharmaceutics and Biopharmaceutics*, 139, 123-130. 10. Martinez, R., & Gomez, A. (2022). Exploring maleimide-activated BSA for targeted delivery of RNA therapeutics. *RNA Biology*, 19(4), 456-465. <a href="Maleimide Activated BSA ML">https://pubmed.ncbi.nlm.nih.gov/?term=Maleimide Activated BSA ML</a> <br><strong>Products Related to Maleimide Activated BSA ML can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021937 (2 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rabbit Polyclonal MCAF1 Antibody [HRP]
NB100-438H 0.1 mL

Rabbit Polyclonal MCAF1 Antibody [HRP]

Ask
View Details
Pi4kb (NM_031083) Rat Tagged Lenti ORF Clone
RR209385L3 10 µg

Pi4kb (NM_031083) Rat Tagged Lenti ORF Clone

Ask
View Details
Human C10ORF93 Protein Lysate
MBS138154-01 0.02 mg

Human C10ORF93 Protein Lysate

Ask
View Details
Human C10ORF93 Protein Lysate
MBS138154-02 5x 0.02 mg

Human C10ORF93 Protein Lysate

Ask
View Details
Mouse Monoclonal Complement Component C3aR Antibody (3G7) [DyLight 650]
NBP2-81062C 0.1 mL

Mouse Monoclonal Complement Component C3aR Antibody (3G7) [DyLight 650]

Ask
View Details
Respiratory Syncytial Virus (RSV, RSV Whole Virus) (AP)
MBS6453456-01 0.1 mL

Respiratory Syncytial Virus (RSV, RSV Whole Virus) (AP)

Ask
View Details